Portola Pharmaceuticals Inc. buy marge
Start price
23.07.15
/
50%
€48.25
Target price
18.07.16
€54.12
Performance (%)
-57.92%
End price
18.07.16
€20.30
Summary
This prediction ended on 18.07.16 with a price of €20.30. The BUY prediction by marge for Portola Pharmaceuticals Inc. performed very badly with a performance of -57.92%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Portola Pharmaceuticals Inc. | 0.012% | 0.012% | -32.057% | -67.867% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% | 70.602% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% | 103.322% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% | 44.593% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% | 64.741% |
Comments by marge for this prediction
In the thread Portola Pharmaceuticals Inc. diskutieren
Portola Pharma
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Laufzeit überschritten)
Stopped prediction by marge for Portola Pharmaceuticals Inc.
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.69
01.01.19
01.01.19
€19.00
06.07.20
06.07.20
-4.09%
06.07.20
06.07.20
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€49.88
28.06.17
28.06.17
€54.12
20.12.18
20.12.18
-70.04%
20.12.18
20.12.18
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€39.41
21.06.15
21.06.15
€45.00
22.07.15
22.07.15
18.34%
22.07.15
22.07.15